These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17456056)

  • 1. Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
    Lietz A; Janz M; Sigvardsson M; Jundt F; Dörken B; Mathas S
    Br J Haematol; 2007 May; 137(4):342-8. PubMed ID: 17456056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
    Mathas S; Janz M; Hummel F; Hummel M; Wollert-Wulf B; Lusatis S; Anagnostopoulos I; Lietz A; Sigvardsson M; Jundt F; Jöhrens K; Bommert K; Stein H; Dörken B
    Nat Immunol; 2006 Feb; 7(2):207-15. PubMed ID: 16369535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
    Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
    Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
    Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
    Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
    Kee BL; Murre C
    J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development.
    Kwon K; Hutter C; Sun Q; Bilic I; Cobaleda C; Malin S; Busslinger M
    Immunity; 2008 Jun; 28(6):751-62. PubMed ID: 18538592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic regulation of bone development.
    Horowitz MC; Lorenzo JA
    Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
    Seet CS; Brumbaugh RL; Kee BL
    J Exp Med; 2004 Jun; 199(12):1689-700. PubMed ID: 15210745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.
    Fedl AS; Tagoh H; Gruenbacher S; Sun Q; Schenk RL; Froussios K; Jaritz M; Busslinger M; Schwickert TA
    Nat Immunol; 2024 Sep; 25(9):1663-1677. PubMed ID: 39179932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
    Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
    Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of B lymphoid cells in human lymphoma pathogenesis.
    Janz M; Dörken B; Mathas S
    Cell Cycle; 2006 May; 5(10):1057-61. PubMed ID: 16687930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
    Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
    Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.
    Jundt F; Acikgöz O; Kwon SH; Schwarzer R; Anagnostopoulos I; Wiesner B; Mathas S; Hummel M; Stein H; Reichardt HM; Dörken B
    Leukemia; 2008 Aug; 22(8):1587-94. PubMed ID: 18449208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
    Bharti B; Mishra R
    Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of biphenotypic, bigenotypic mature lymphoma.
    Koletsa T; Kotoula V; Christoforidou A; Pantelidou P; Petrakis G; Tsatalas C; Kostopoulos I
    J Clin Pathol; 2013 Dec; 66(12):1090-2. PubMed ID: 23794479
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus.
    Walter K; Bonifer C; Tagoh H
    Blood; 2008 Sep; 112(5):1673-82. PubMed ID: 18552207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.